Package 69097-533-02

{"route": ["ORAL"], "spl_id": "cee87535-9401-4baf-920c-7184d8959c09", "openfda": {"upc": ["0369097533021"], "unii": ["OTT9J7900I"], "rxcui": ["349251"], "spl_set_id": ["de27413a-6579-4586-80dc-39c712652952"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (69097-533-02)", "package_ndc": "69097-533-02", "marketing_start_date": "20180126"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (69097-533-15)", "package_ndc": "69097-533-15", "marketing_start_date": "20180126"}], "brand_name": "Tenofovir disoproxil fumarate", "product_id": "69097-533_cee87535-9401-4baf-920c-7184d8959c09", "dosage_form": "TABLET", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]"], "product_ndc": "69097-533", "generic_name": "Tenofovir disoproxil fumarate", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tenofovir disoproxil fumarate", "active_ingredients": [{"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "300 mg/1"}], "application_number": "ANDA078800", "marketing_category": "ANDA", "marketing_start_date": "20180126", "listing_expiration_date": "20261231"}